One of the histological and molecular subtypes of ovarian cancer is low-grade serous (LGS) ovarian carcinoma characterized by BRAF, KRAS, NRAS and ERBB2 mutation, amplification or overexpression[42, 43]. Here, KRAS is linked to ovarian carcinoma.